Iron Supplementation for Geriatric Hip Fractures

Launched by HE QIFEI · Aug 4, 2022

Keywords

ClinConnect Summary

This clinical trial is studying how iron supplementation can help elderly patients who have suffered hip fractures and have low iron levels or anemia. Researchers want to see if giving intravenous iron during and after surgery can improve these patients' ability to move around and their overall quality of life. They will compare two groups: one that receives the iron treatment and one that follows the traditional care method without iron. The study will look at various outcomes, such as how far patients can walk and their overall health scores, six months after their surgery.

To participate in this trial, you need to be over 65 years old and have a hip fracture along with iron deficiency or anemia. There are some important health conditions that would exclude you from joining, such as recent heart surgery or other serious health issues. If you qualify, you can expect to receive care that includes either iron supplementation or standard treatment during your recovery. This study is currently recruiting participants, and it aims to provide valuable information about improving recovery for older adults facing hip fractures.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. \>65 years old patients with hip fracture
• • 2. Patients with iron deficiency or anemia,
• • preoperative hemoglobin \<13g/ dL in males and \<12g/ dL in females, and \>9g/ dL,
• • serum ferritin \< 100 ng/ mL or serum ferritin 100-299 ng/ mL or transferrin saturation (TSAT) \<20%
• Exclusion Criteria:
• • 1. Coronary artery bypass grafting, percutaneous transluminal coronary angioplasty, and cardiac device implantation (including cardiac resynchronization) within preoperative 30 days
• • 2. Acute coronary syndrome, transient ischemic attack or stroke occurred within 30 days before surgery;
• • 3. Refused to sign the consent form to be included in the clinical trial group;
• • 4. Can't walk before injury;
• • 5. Use erythropoietic preparation within 3 months before surgery and oral iron preparation within 4 weeks 30 days before surgery(\> 100 mg/ day)
• • 6. Patients with liver and kidney dysfunction
• • 7. Other conditions that the researchers considered inappropriate for inclusion